JB Chemicals & Pharmaceuticals Ltd. - (Amalgamated)
₹2,408.9
-97.1 (-3.9%)
JBCHEPHARM Share Price
As on July 16, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 37,575 Cr
P/E Ratio54.52
Dividend Yield0.91 %
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open2,506
High2,525.5
NSE SymbolJBCHEPHARM
Close2,408.9
Low2,380
BSE Symbol506943
Previous Years High/Low
1 Year High2,525.5
3 Year High2,525.5
5 Year High2,525.5
1 Year Low1,638.5
3 Year Low1,244.45
5 Year Low671.1
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 2,459.6 | Bearish |
| 10-DMA | 2,435.49 | Bearish |
| 20-DMA | 2,344.26 | Bullish |
| 50-DMA | 2,241.45 | Bullish |
| 100-DMA | 2,142.02 | Bullish |
| 200-DMA | 1,965.87 | Bullish |
Historical Performance
1 Year
40.4%
3 Years
79.8%
5 Years
171.1%
10 Years
1613.3%
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 41,478 | 39,180 | 34,842 | 31,493 | 24,242 |
| Total Expenditure | 30,420 | 28,869 | 25,917 | 24,535 | 18,816 |
| Other Income | 618 | 390 | 417 | 99 | 401 |
| Operating Profit | 11,676 | 10,702 | 9,342 | 7,057 | 5,827 |
| Interest | 56 | 117 | 443 | 361 | 51 |
| Depreciation | 1,825 | 1,710 | 1,383 | 1,144 | 727 |
| Profit Before Tax | 9,523 | 8,874 | 7,515 | 5,552 | 5,049 |
| Consolidated Net Profit | 7,095 | 6,596 | 5,526 | 4,098 | 3,854 |
| Adjusted EPS | 44 | 42 | 36 | 26 | 25 |
Compounded Sales Growth
10 Years:27.5
5 Years:15.2
3 Years:5.7
TTM:1.1
Compounded Profit Growth
10 Years:34.3
5 Years:9.6
3 Years:11.6
TTM:1.5
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:10.9
5 Years:24.9
3 Years:35.6
last year:44.2
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 161 | 156 | 155 | 155 | 155 |
| Total Reserves | 41,432 | 32,497 | 27,680 | 23,433 | 20,560 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 6,790 | 4,432 | 4,660 | 9,920 | 4,753 |
| Other Current Liabilities | 1,257 | 1,373 | 4,358 | 2,403 | 813 |
| Short Term Borrowings | --- | 138 | 153 | 280 | 263 |
| Total Liabilities | 58,756 | 50,335 | 46,770 | 40,981 | 30,691 |
| Capital Work in Progress | 612 | 467 | 633 | 444 | 139 |
| Long Term Loans & Advances | 5,139 | 2,759 | 2,936 | 5,143 | 4,351 |
| Currents Investments | 7,389 | 3,171 | 3,647 | 1,922 | --- |
| Short Term Loans and Advances | 9,517 | 6,271 | 5,902 | 2,771 | 2,430 |
| Total Current Assets | 33,556 | 24,473 | 22,729 | 15,993 | 13,246 |
| Total Assets | 58,756 | 50,335 | 46,770 | 40,981 | 30,691 |
| Adjusted Book Value | 259 | 210 | 179 | 152 | 134 |
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 54.52, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered a strong 3-year price CAGR of 34.2%, indicating sustained price appreciation.
- The stock carries a low beta of 0.3, suggesting lower volatility than the broader market.
- In the last financial year, the company reported an EBITDA of ₹11676 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹41478 million, indicating a large and established business.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1403215.5
No. of Shares: 583 (Approx)
Performance:40.3%
403215.5
NIFTY Performance: -1%
1 day Top Gainers
1 Day Top Losers
| Symbol | Change% |
|---|---|
| NATIONALUM | 400.5(-5%) |
| PAGEIND | 36520(-5%) |
| APARINDS | 17225(-4%) |
| FORCEMOT | 18525(-4%) |
| SCHNEIDER | 1379.1(-4%) |
| BALKRISIND | 2410(-4%) |
| MINDACORP | 712.05(-3%) |
| WELSPUNLIV | 159.83(-3%) |
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
